SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Journey Medical Corporation Reports Third Quarter 2026 Financial Results and Recent Corporate Highlights

Total revenues were $19.0 million for the third quarter of 2026 Emrosi® revenues of $9.0 million inc

DERMFBIO

Related stories